K. Dvir, G. G. Fortuna, Nathaly Cortez, V. Guerra, M. Cusnir
{"title":"Advances in Cholangiocarcinoma Treatment in the Personalized Medicine Era","authors":"K. Dvir, G. G. Fortuna, Nathaly Cortez, V. Guerra, M. Cusnir","doi":"10.17352/ojh.000004","DOIUrl":null,"url":null,"abstract":"Cholangiocarcinoma is amongst the most common primary tumors of the liver, second only to hepatocellular carcinoma, and it accounts for approximately 15% of primary hepatic malignancies [1].","PeriodicalId":288820,"journal":{"name":"Open Journal of Hepatology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Journal of Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17352/ojh.000004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Cholangiocarcinoma is amongst the most common primary tumors of the liver, second only to hepatocellular carcinoma, and it accounts for approximately 15% of primary hepatic malignancies [1].
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
